Ajanta Pharma Limited — Others, 07-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Ajanta Pharma Limited has provided a certificate confirming the dematerialization process of securities for the quarter ended December 31, 2024, as per SEBI regulations. This ensures that any physical shares have been transitioned to electronic form, enhancing liquidity and accessibility for investors. The confirmation indicates that securities have been accepted by depositories, which should reassure shareholders regarding the company's compliance and operational efficiency. This development could positively influence investor sentiment by reinforcing confidence in Ajanta Pharma's governance and its commitment to maintaining effective share management.